Abstract

Pediatric TransplantationVolume 13, Issue 4 p. 393-396 Optimal treatment for chronic active Epstein–Barr virus disease Jeffrey I. Cohen, Jeffrey I. Cohen Medical Virology Section, Laboratory of Clinical Infectious Diseases, National Institutes of Health, Bethesda, MD, USAE-mail: jcohen@niaid.nih.govSearch for more papers by this author Jeffrey I. Cohen, Jeffrey I. Cohen Medical Virology Section, Laboratory of Clinical Infectious Diseases, National Institutes of Health, Bethesda, MD, USAE-mail: jcohen@niaid.nih.govSearch for more papers by this author First published: 05 May 2009 https://doi.org/10.1111/j.1399-3046.2008.01095.xCitations: 35Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume13, Issue4June 2009Pages 393-396 RelatedInformation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call